# Medline Inc.: filings

MDLN · Nasdaq · CIK 2046386 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mdln.md) · [Financials](/companies/mdln/financials.md) · [Filings](/companies/mdln/filings.md) · [Insiders](/companies/mdln/insiders.md)

## Reports and events: 18 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 65, 3 33, 8-K 9, SCHEDULE 13G 7, SCHEDULE 13G/A 7, DRS/A 4, 424B4 3, DRS 3, EFFECT 3, S-1 3, 10-Q 2, CORRESP 2, S-1/A 2, S-1MEF 2, S-8 2, UPLOAD 2, 10-K 1, 144 1, 8-A12B 1, ARS 1, CERT 1, DEF 14A 1, DEFA14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 16:17 ET | [8-K](/filings/0001104659-26-117844.md) | 7.01 Regulation FD disclosure | 0001104659-26-117844 |
| 2026-10-15 | 16:18 ET | [8-K](/filings/0001104659-26-116255.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-116255 |
| 2026-08-05 | 16:48 ET | [10-Q](/filings/0002046386-26-000051.md) | Quarterly report, period 2026-06-27 | 0002046386-26-000051 |
| 2026-08-05 | 07:34 ET | [8-K](/filings/0002046386-26-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002046386-26-000049 |
| 2026-07-09 | 16:00 ET | [8-K](/filings/0001104659-26-082249.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-082249 |
| 2026-06-12 | 16:20 ET | [8-K](/filings/0002046386-26-000037.md) | 5.07 Shareholder vote results | 0002046386-26-000037 |
| 2026-06-02 | 08:06 ET | [8-K](/filings/0001193125-26-252557.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-252557 |
| 2026-05-20 | 07:01 ET | [S-1](/filings/0001193125-26-231691.md) | Registration statement | 0001193125-26-231691 |
| 2026-05-06 | 16:18 ET | [10-Q](/filings/0002046386-26-000026.md) | Quarterly report, period 2026-03-28 | 0002046386-26-000026 |
| 2026-05-06 | 07:35 ET | [8-K](/filings/0002046386-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002046386-26-000022 |
| 2026-04-23 | 06:05 ET | [DEF 14A](/filings/0001104659-26-047092.md) | Proxy statement, period 2026-06-11 | 0001104659-26-047092 |
| 2026-03-03 | 06:57 ET | [S-1](/filings/0001193125-26-086603.md) | Registration statement | 0001193125-26-086603 |
| 2026-02-25 | 16:51 ET | [10-K](/filings/0002046386-26-000009.md) | Annual report, period 2025-12-31 | 0002046386-26-000009 |
| 2026-02-25 | 07:38 ET | [8-K](/filings/0002046386-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002046386-26-000007 |
| 2025-12-22 | 16:48 ET | [8-K](/filings/0001193125-25-328884.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-328884 |
| 2025-12-08 | 15:05 ET | [S-1/A](/filings/0001193125-25-311099.md) | Registration statement, amended | 0001193125-25-311099 |
| 2025-11-04 | 16:28 ET | [S-1/A](/filings/0001193125-25-264798.md) | Registration statement, amended | 0001193125-25-264798 |
| 2025-10-28 | 13:05 ET | [S-1](/filings/0001193125-25-253020.md) | Registration statement | 0001193125-25-253020 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 15:07 ET. No prices; not investment advice.